-
1
-
-
23044496541
-
-
note
-
Deleted in proof.
-
-
-
-
2
-
-
23044502064
-
-
note
-
Deleted in proof.
-
-
-
-
3
-
-
0031038918
-
Alzheimer's disease: Genotypes, phenotypes and treatments
-
Selkoe DJ. Alzheimer's disease: genotypes, phenotypes and treatments. Science. 1997;275:630-631.
-
(1997)
Science
, vol.275
, pp. 630-631
-
-
Selkoe, D.J.1
-
4
-
-
0030611097
-
Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
-
Irizarry MC, Soriano F, McNamara M, et al. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci. 1997;17:7053-7059.
-
(1997)
J Neurosci
, vol.17
, pp. 7053-7059
-
-
Irizarry, M.C.1
Soriano, F.2
McNamara, M.3
-
7
-
-
0035997240
-
The state versus amyloid-β: The trial of the most wanted criminal in Alzheimer disease
-
Rottkamp CA, Atwood CS, Joseph JA, et al. The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease. Peptides. 2002;23:1333-1341.
-
(2002)
Peptides
, vol.23
, pp. 1333-1341
-
-
Rottkamp, C.A.1
Atwood, C.S.2
Joseph, J.A.3
-
8
-
-
3242737470
-
Challenging the amyloid cascade hypothesis: Senile plaques and amyloid-beta as protective adaptations to Alzheimer disease
-
Lee HG, Casadesus G, Zhu X, et al. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci. 2004;1019:1-4.
-
(2004)
Ann N Y Acad Sci
, vol.1019
, pp. 1-4
-
-
Lee, H.G.1
Casadesus, G.2
Zhu, X.3
-
9
-
-
0033301774
-
Elevated levels of tau in cerebrospinal fluid: Implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid
-
Trojanowski JQ, Clark CM, Arai H, et al. Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid. J Alzheimers Dis. 1999;1:297-305.
-
(1999)
J Alzheimers Dis
, vol.1
, pp. 297-305
-
-
Trojanowski, J.Q.1
Clark, C.M.2
Arai, H.3
-
10
-
-
0034733799
-
Tau aggregation into fibrillar polymers: Taupathies
-
Avila J. Tau aggregation into fibrillar polymers: taupathies. FEBS Lett. 2000;476:89-92.
-
(2000)
FEBS Lett
, vol.476
, pp. 89-92
-
-
Avila, J.1
-
11
-
-
0036770144
-
The role of mitogen-activated protein kinase pathways in Alzheimer disease
-
Zhu X, Perry G, Raina AK, et al. The role of mitogen-activated protein kinase pathways in Alzheimer disease. Neurosignals. 2002;11:270-281.
-
(2002)
Neurosignals
, vol.11
, pp. 270-281
-
-
Zhu, X.1
Perry, G.2
Raina, A.K.3
-
12
-
-
0032229327
-
Reactive oxygen species mediate cellular damage in Alzheimer disease
-
Perry G, Castellani RJ, Hirai K, et al. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis. 1998;1:45-55.
-
(1998)
J Alzheimers Dis
, vol.1
, pp. 45-55
-
-
Perry, G.1
Castellani, R.J.2
Hirai, K.3
-
13
-
-
0036113819
-
The role of iron and copper in the aetiology of neurodegenerative disorders: Therapeutic implications
-
Perry G, Sayre LM, Atwood CS, et al. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs. 2002;16:339-352.
-
(2002)
CNS Drugs
, vol.16
, pp. 339-352
-
-
Perry, G.1
Sayre, L.M.2
Atwood, C.S.3
-
14
-
-
0002451682
-
Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits
-
Iqbal K, Sisoda SS, Winbald B, eds. UK: John Wiley & Sons, Ltd
-
Atwood CS, Huang X, Moir RD, et al. Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits. In: Iqbal K, Sisoda SS, Winbald B, eds. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. UK: John Wiley & Sons, Ltd; 2001:341-361.
-
(2001)
Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics
, pp. 341-361
-
-
Atwood, C.S.1
Huang, X.2
Moir, R.D.3
-
15
-
-
0028603650
-
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France
-
Letenneur L, Commenges D, Dartigues JF, et al. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol. 1994;26:1256-1261.
-
(1994)
Int J Epidemiol
, vol.26
, pp. 1256-1261
-
-
Letenneur, L.1
Commenges, D.2
Dartigues, J.F.3
-
16
-
-
0031024278
-
Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm
-
Fratiglioni L, Viitanen M, Strauss EV, et al. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132-138.
-
(1997)
Neurology
, vol.48
, pp. 132-138
-
-
Fratiglioni, L.1
Viitanen, M.2
Strauss, E.V.3
-
17
-
-
0023628422
-
The prevalence of dementia: A quantitative integration of the literature
-
Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
-
(1987)
Acta Psychiatr Scand
, vol.76
, pp. 465-479
-
-
Jorm, A.F.1
Korten, A.E.2
Henderson, A.S.3
-
18
-
-
0023853488
-
Familial aggregation in Alzheimer's disease: Comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations
-
Breitner JCS, Silverman JM, Mohs RC, et al. Familial aggregation in Alzheimer's disease: Comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology. 1988;38:207-212.
-
(1988)
Neurology
, vol.38
, pp. 207-212
-
-
Breitner, J.C.S.1
Silverman, J.M.2
Mohs, R.C.3
-
19
-
-
0025989415
-
Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings
-
The EURODEM-Prevalence Research Group
-
Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol. 1991;30:381-390.
-
(1991)
Ann Neurol
, vol.30
, pp. 381-390
-
-
Rocca, W.A.1
Hofman, A.2
Brayne, C.3
-
20
-
-
0027447726
-
Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88
-
McGonigal G, Thamas B, McQuade C, et al. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. BMJ. 1993;306:680-683.
-
(1993)
BMJ
, vol.306
, pp. 680-683
-
-
McGonigal, G.1
Thamas, B.2
McQuade, C.3
-
21
-
-
0031720801
-
The incidence of dementia: A meta-analysis
-
Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728-733.
-
(1998)
Neurology
, vol.51
, pp. 728-733
-
-
Jorm, A.F.1
Jolley, D.2
-
22
-
-
0034700965
-
Endogenous estrogen levels and Alzheimer's disease among postmenopausal women
-
Manly JJ, Merchant CA, Jacobs DM, et al. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology. 2000;54:833-837.
-
(2000)
Neurology
, vol.54
, pp. 833-837
-
-
Manly, J.J.1
Merchant, C.A.2
Jacobs, D.M.3
-
23
-
-
0028086440
-
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects
-
Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994;51:896-900.
-
(1994)
Arch Neurol
, vol.51
, pp. 896-900
-
-
Henderson, V.W.1
Paganini-Hill, A.2
Emanuel, C.K.3
-
24
-
-
0030591669
-
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
-
Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.
-
(1996)
Lancet
, vol.348
, pp. 429-432
-
-
Tang, M.X.1
Jacobs, D.2
Stern, Y.3
-
25
-
-
0030748719
-
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
-
Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517-1521.
-
(1997)
Neurology
, vol.48
, pp. 1517-1521
-
-
Kawas, C.1
Resnick, S.2
Morrison, A.3
-
26
-
-
0037032405
-
Hormone therapy and risk of Alzheimer disease: A critical time
-
Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288:2170-2172.
-
(2002)
JAMA
, vol.288
, pp. 2170-2172
-
-
Resnick, S.M.1
Henderson, V.W.2
-
27
-
-
0038386058
-
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative memory study: A randomized controlled trial
-
Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative memory study: a randomized controlled trial. JAMA. 2003;289:2651-2662.
-
(2003)
JAMA
, vol.289
, pp. 2651-2662
-
-
Shumaker, S.A.1
Legault, C.2
Rapp, S.R.3
-
28
-
-
0030609088
-
Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in rat
-
Shi J, Zhang YQ, Simpkins JW. Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in rat. Exp Brain Res. 1997;117:200-206.
-
(1997)
Exp Brain Res
, vol.117
, pp. 200-206
-
-
Shi, J.1
Zhang, Y.Q.2
Simpkins, J.W.3
-
29
-
-
0343673804
-
Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women: The Iowa women's health study
-
Jacobs DR, Pereira MA, Meyer KA, et al. Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women: the Iowa women's health study. J Am Coll Nutr. 2000;19:326S-330S.
-
(2000)
J Am Coll Nutr
, vol.19
-
-
Jacobs, D.R.1
Pereira, M.A.2
Meyer, K.A.3
-
31
-
-
0037269433
-
Measuring serum oestradiol in women with Alzheimer's disease: The importance of the sensitivity of the assay method
-
Hogervorst E, Williams J, Combrinck M, et al. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol. 2003;148:67-72.
-
(2003)
Eur J Endocrinol
, vol.148
, pp. 67-72
-
-
Hogervorst, E.1
Williams, J.2
Combrinck, M.3
-
32
-
-
0038724280
-
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial
-
WHIMS Investigators
-
Rapp SR, Espeland MA, Shumaker SA, et al. WHIMS Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;20:2663-2672.
-
(2003)
JAMA
, vol.20
, pp. 2663-2672
-
-
Rapp, S.R.1
Espeland, M.A.2
Shumaker, S.A.3
-
33
-
-
0031948289
-
Earlier onset of Alzheimer's disease in men with Down syndrome
-
Schupf N, Kapell D, Nightingale B, et al. Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology. 1998;50:991-995.
-
(1998)
Neurology
, vol.50
, pp. 991-995
-
-
Schupf, N.1
Kapell, D.2
Nightingale, B.3
-
34
-
-
0031054674
-
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
-
Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.
-
(1997)
JAMA
, vol.277
, pp. 813-817
-
-
Snowdon, D.A.1
Greiner, L.H.2
Mortimer, J.A.3
-
36
-
-
0036790467
-
Activins, inhibins, and follistatins: From endocrinology to signaling. A paradigm for the new millennium
-
Welt C, Sidis Y, Keutmann H, et al. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med. 2002;227:724-752.
-
(2002)
Exp Biol Med
, vol.227
, pp. 724-752
-
-
Welt, C.1
Sidis, Y.2
Keutmann, H.3
-
37
-
-
0027375544
-
The control of gonadotropin secretion by ovarian steroids
-
Couzinet B, Schaison G. The control of gonadotropin secretion by ovarian steroids. Hum Reprod Suppl. 1993;2:97-101.
-
(1993)
Hum Reprod Suppl
, vol.2
, pp. 97-101
-
-
Couzinet, B.1
Schaison, G.2
-
39
-
-
0021123879
-
Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men
-
Neaves WB, Johnson L, Porter JC, et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab. 1984;59:756-763.
-
(1984)
J Clin Endocrinol Metab
, vol.59
, pp. 756-763
-
-
Neaves, W.B.1
Johnson, L.2
Porter, J.C.3
-
40
-
-
0027210341
-
Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain
-
Lei ZM, Rao CV, Kornyei JL, et al. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 1993;132:2262-2270.
-
(1993)
Endocrinology
, vol.132
, pp. 2262-2270
-
-
Lei, Z.M.1
Rao, C.V.2
Kornyei, J.L.3
-
41
-
-
0037010296
-
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology
-
Bowen RL, Smith MA, Harris PLR, et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70:514-518.
-
(2002)
J Neurosci Res
, vol.70
, pp. 514-518
-
-
Bowen, R.L.1
Smith, M.A.2
Harris, P.L.R.3
-
42
-
-
0034661784
-
Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease
-
Raina AK, Zhu X, Rottkamp CA, et al. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res. 2000;61:128-133.
-
(2000)
J Neurosci Res
, vol.61
, pp. 128-133
-
-
Raina, A.K.1
Zhu, X.2
Rottkamp, C.A.3
-
43
-
-
0036592637
-
Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle
-
Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis. 2002;4:249-254.
-
(2002)
J Alzheimers Dis
, vol.4
, pp. 249-254
-
-
Bowser, R.1
Smith, M.A.2
-
44
-
-
24344482275
-
Alzheimer disease - A new beginning, or a final exit?
-
Copani A, Nicoletti F, eds. TX: Landes Bioscience
-
Obrenovich ME, Raina A, Ogawa O, et al. Alzheimer disease-a new beginning, or a final exit? In: Copani A, Nicoletti F, eds. The Cell Cycle and Neuronal Cell Death. TX: Landes Bioscience; 2003.
-
(2003)
The Cell Cycle and Neuronal Cell Death
-
-
Obrenovich, M.E.1
Raina, A.2
Ogawa, O.3
-
45
-
-
0030921323
-
Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease
-
McShea A, Harris PLR, Webster KR, et al. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol. 1997;150:1933-1939.
-
(1997)
Am J Pathol
, vol.150
, pp. 1933-1939
-
-
McShea, A.1
Harris, P.L.R.2
Webster, K.R.3
-
46
-
-
0035341254
-
Mitochondrial abnormalities in Alzheimer's disease
-
Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001;21:3017-3023.
-
(2001)
J Neurosci
, vol.21
, pp. 3017-3023
-
-
Hirai, K.1
Aliev, G.2
Nunomura, A.3
-
47
-
-
0033782845
-
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease
-
Zhu X, Rottkamp CA, Boux H, et al. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol. 2000;59:880-888.
-
(2000)
J Neuropathol Exp Neurol
, vol.59
, pp. 880-888
-
-
Zhu, X.1
Rottkamp, C.A.2
Boux, H.3
-
48
-
-
0033516947
-
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
-
Perry G, Roder H, Nunomura A, et al. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport. 1999;10:2411-2415.
-
(1999)
Neuroreport
, vol.10
, pp. 2411-2415
-
-
Perry, G.1
Roder, H.2
Nunomura, A.3
-
49
-
-
0034797352
-
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: The "two hit" hypothesis
-
Zhu X, Castellani RJ, Takeda A, et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the "two hit" hypothesis. Mech Ageing Dev. 2001;123:39-46.
-
(2001)
Mech Ageing Dev
, vol.123
, pp. 39-46
-
-
Zhu, X.1
Castellani, R.J.2
Takeda, A.3
-
50
-
-
0036173664
-
Activation of MAPK cascades by GnRH: ERK and Jun N-terminal kinase are involved in basal and GnRH-stimulated activity of the glycoprotein hormone LHβ-subunit promoter
-
Harris D, Bonfil D, Chuderland D, et al. Activation of MAPK cascades by GnRH: ERK and Jun N-terminal kinase are involved in basal and GnRH-stimulated activity of the glycoprotein hormone LHβ-subunit promoter. Endocrinology. 2002;143:1018-1025.
-
(2002)
Endocrinology
, vol.143
, pp. 1018-1025
-
-
Harris, D.1
Bonfil, D.2
Chuderland, D.3
-
51
-
-
0031685160
-
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
-
Vincent I, Zheng JH, Dickson DW, et al. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging. 1998;19:287-296.
-
(1998)
Neurobiol Aging
, vol.19
, pp. 287-296
-
-
Vincent, I.1
Zheng, J.H.2
Dickson, D.W.3
-
52
-
-
0034114486
-
An association of elevated serum gonadotropin concentrations and Alzheimer disease?
-
Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12:351-354.
-
(2000)
J Neuroendocrinol
, vol.12
, pp. 351-354
-
-
Bowen, R.L.1
Isley, J.P.2
Atkinson, R.L.3
-
53
-
-
0034846382
-
Elevated gonadotropin levels in patients with Alzheimer disease
-
Short RA, Bowen RL, O'Brien PC, et al. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76:906-909.
-
(2001)
Mayo Clin Proc
, vol.76
, pp. 906-909
-
-
Short, R.A.1
Bowen, R.L.2
O'Brien, P.C.3
-
54
-
-
0028959562
-
Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats
-
Lukacs H, Hiatt ES, Lei ZM, et al. Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav. 1995;29:42-58.
-
(1995)
Horm Behav
, vol.29
, pp. 42-58
-
-
Lukacs, H.1
Hiatt, E.S.2
Lei, Z.M.3
-
55
-
-
0041419869
-
Increased p27, an essential component of cell cycle control, in Alzheimer's disease
-
Ogawa O, Lee HG, Zhu X, et al. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell. 2003;2:105-110.
-
(2003)
Aging Cell
, vol.2
, pp. 105-110
-
-
Ogawa, O.1
Lee, H.G.2
Zhu, X.3
-
56
-
-
0034923434
-
Oxidative damage is the earliest event in Alzheimer disease
-
Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:759-767.
-
(2001)
J Neuropathol Exp Neurol
, vol.60
, pp. 759-767
-
-
Nunomura, A.1
Perry, G.2
Aliev, G.3
-
57
-
-
0034686614
-
Estrogen as a treatment for alzheimer disease
-
Mulnard RA. Estrogen as a treatment for alzheimer disease. JAMA. 2000;284:307-308.
-
(2000)
JAMA
, vol.284
, pp. 307-308
-
-
Mulnard, R.A.1
-
58
-
-
0034704547
-
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study
-
Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283:1007-1015.
-
(2000)
JAMA
, vol.283
, pp. 1007-1015
-
-
Mulnard, R.A.1
Cotman, C.W.2
Kawas, C.3
-
59
-
-
0027285453
-
Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism
-
Varney NR, Syrop C, Kubu CS, et al. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet. 1993;10:53-57.
-
(1993)
J Assist Reprod Genet
, vol.10
, pp. 53-57
-
-
Varney, N.R.1
Syrop, C.2
Kubu, C.S.3
-
60
-
-
0029900525
-
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri
-
Sherwin BB, Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996;81:2545-2549.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2545-2549
-
-
Sherwin, B.B.1
Tulandi, T.2
|